Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Buy
58
UFPT Quote, Financials, Valuation and Earnings
Last price:
$217.52
Seasonality move
:
7.33%
Day range:
$213.18 - $219.95
52-week range:
$178.26 - $297.40
Dividend yield:
0%
P/E ratio:
25.17x
P/S ratio:
2.83x
P/B ratio:
4.15x
Volume:
134.3K
Avg. volume:
140.1K
1-year change:
-25.12%
Market cap:
$1.7B
Revenue:
$504.4M
EPS (TTM):
$8.63
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
UFPT
UFP Technologies, Inc.
|
$149.6M | $2.17 | 3.47% | 6.38% | $329.50 |
|
CATX
Perspective Therapeutics, Inc.
|
$206.8K | -$0.32 | -9.65% | -37.91% | $12.3077 |
|
ISRG
Intuitive Surgical, Inc.
|
$2.4B | $1.99 | 12.86% | 18.99% | $596.36 |
|
MASI
Masimo Corp.
|
$366.9M | $1.20 | -32.15% | 565.51% | $183.75 |
|
VNRX
VolitionRX Ltd.
|
$715.6K | -$0.05 | 272.5% | -33.67% | $2.60 |
|
XTNT
Xtant Medical Holdings, Inc.
|
$32.7M | -- | 2.34% | -100% | $1.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
UFPT
UFP Technologies, Inc.
|
$217.14 | $329.50 | $1.7B | 25.17x | $0.00 | 0% | 2.83x |
|
CATX
Perspective Therapeutics, Inc.
|
$2.4000 | $12.3077 | $178.4M | -- | $0.00 | 0% | 162.73x |
|
ISRG
Intuitive Surgical, Inc.
|
$575.34 | $596.36 | $204B | 76.15x | $0.00 | 0% | 21.76x |
|
MASI
Masimo Corp.
|
$141.68 | $183.75 | $7.6B | 116.80x | $0.00 | 0% | 4.48x |
|
VNRX
VolitionRX Ltd.
|
$0.30 | $2.60 | $36.8M | -- | $0.00 | 0% | 20.54x |
|
XTNT
Xtant Medical Holdings, Inc.
|
$0.62 | $1.50 | $86.2M | 60.39x | $0.00 | 0% | 0.67x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
UFPT
UFP Technologies, Inc.
|
29.07% | 2.066 | 10.75% | 1.27x |
|
CATX
Perspective Therapeutics, Inc.
|
1.35% | 3.691 | 1.3% | 8.47x |
|
ISRG
Intuitive Surgical, Inc.
|
-- | 1.065 | -- | 3.42x |
|
MASI
Masimo Corp.
|
41.99% | 0.805 | 7.4% | 1.68x |
|
VNRX
VolitionRX Ltd.
|
-48.16% | 2.566 | 15.4% | 0.04x |
|
XTNT
Xtant Medical Holdings, Inc.
|
39.2% | 2.955 | 35.76% | 1.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
UFPT
UFP Technologies, Inc.
|
$42.7M | $23.7M | 11.98% | 18.42% | 15.32% | $32.5M |
|
CATX
Perspective Therapeutics, Inc.
|
-$566K | -$27.9M | -37.13% | -37.63% | -13330.62% | -$18.3M |
|
ISRG
Intuitive Surgical, Inc.
|
$1.7B | $759.7M | 16.35% | 16.38% | 30.33% | $735.6M |
|
MASI
Masimo Corp.
|
$230.6M | $83.7M | -11.41% | -19.18% | 22.53% | $49.7M |
|
VNRX
VolitionRX Ltd.
|
$318.2K | -$5.1M | -- | -- | -813.17% | -$3.5M |
|
XTNT
Xtant Medical Holdings, Inc.
|
$22M | $2.5M | 2.15% | 3.78% | 7.64% | $4.2M |
UFP Technologies, Inc. vs. Competitors
-
Which has Higher Returns UFPT or CATX?
Perspective Therapeutics, Inc. has a net margin of 10.6% compared to UFP Technologies, Inc.'s net margin of -12425.36%. UFP Technologies, Inc.'s return on equity of 18.42% beat Perspective Therapeutics, Inc.'s return on equity of -37.63%.
Company Gross Margin Earnings Per Share Invested Capital UFPTUFP Technologies, Inc.27.66% $2.11 $569.4M CATXPerspective Therapeutics, Inc.-270.81% -$0.35 $245.5M -
What do Analysts Say About UFPT or CATX?
UFP Technologies, Inc. has a consensus price target of $329.50, signalling upside risk potential of 51.75%. On the other hand Perspective Therapeutics, Inc. has an analysts' consensus of $12.3077 which suggests that it could grow by 412.82%. Given that Perspective Therapeutics, Inc. has higher upside potential than UFP Technologies, Inc., analysts believe Perspective Therapeutics, Inc. is more attractive than UFP Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings UFPTUFP Technologies, Inc.1 2 0 CATXPerspective Therapeutics, Inc.12 1 0 -
Is UFPT or CATX More Risky?
UFP Technologies, Inc. has a beta of 1.103, which suggesting that the stock is 10.324% more volatile than S&P 500. In comparison Perspective Therapeutics, Inc. has a beta of 1.222, suggesting its more volatile than the S&P 500 by 22.249%.
-
Which is a Better Dividend Stock UFPT or CATX?
UFP Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UFP Technologies, Inc. pays -- of its earnings as a dividend. Perspective Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UFPT or CATX?
UFP Technologies, Inc. quarterly revenues are $154.6M, which are larger than Perspective Therapeutics, Inc. quarterly revenues of $209K. UFP Technologies, Inc.'s net income of $16.4M is higher than Perspective Therapeutics, Inc.'s net income of -$26M. Notably, UFP Technologies, Inc.'s price-to-earnings ratio is 25.17x while Perspective Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UFP Technologies, Inc. is 2.83x versus 162.73x for Perspective Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UFPTUFP Technologies, Inc.2.83x 25.17x $154.6M $16.4M CATXPerspective Therapeutics, Inc.162.73x -- $209K -$26M
-
Which has Higher Returns UFPT or ISRG?
Intuitive Surgical, Inc. has a net margin of 10.6% compared to UFP Technologies, Inc.'s net margin of 28.31%. UFP Technologies, Inc.'s return on equity of 18.42% beat Intuitive Surgical, Inc.'s return on equity of 16.38%.
Company Gross Margin Earnings Per Share Invested Capital UFPTUFP Technologies, Inc.27.66% $2.11 $569.4M ISRGIntuitive Surgical, Inc.66.36% $1.95 $17B -
What do Analysts Say About UFPT or ISRG?
UFP Technologies, Inc. has a consensus price target of $329.50, signalling upside risk potential of 51.75%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $596.36 which suggests that it could grow by 3.65%. Given that UFP Technologies, Inc. has higher upside potential than Intuitive Surgical, Inc., analysts believe UFP Technologies, Inc. is more attractive than Intuitive Surgical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings UFPTUFP Technologies, Inc.1 2 0 ISRGIntuitive Surgical, Inc.15 10 1 -
Is UFPT or ISRG More Risky?
UFP Technologies, Inc. has a beta of 1.103, which suggesting that the stock is 10.324% more volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.682, suggesting its more volatile than the S&P 500 by 68.249%.
-
Which is a Better Dividend Stock UFPT or ISRG?
UFP Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UFP Technologies, Inc. pays -- of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UFPT or ISRG?
UFP Technologies, Inc. quarterly revenues are $154.6M, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.5B. UFP Technologies, Inc.'s net income of $16.4M is lower than Intuitive Surgical, Inc.'s net income of $709.2M. Notably, UFP Technologies, Inc.'s price-to-earnings ratio is 25.17x while Intuitive Surgical, Inc.'s PE ratio is 76.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UFP Technologies, Inc. is 2.83x versus 21.76x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UFPTUFP Technologies, Inc.2.83x 25.17x $154.6M $16.4M ISRGIntuitive Surgical, Inc.21.76x 76.15x $2.5B $709.2M
-
Which has Higher Returns UFPT or MASI?
Masimo Corp. has a net margin of 10.6% compared to UFP Technologies, Inc.'s net margin of 14.46%. UFP Technologies, Inc.'s return on equity of 18.42% beat Masimo Corp.'s return on equity of -19.18%.
Company Gross Margin Earnings Per Share Invested Capital UFPTUFP Technologies, Inc.27.66% $2.11 $569.4M MASIMasimo Corp.62.07% -$1.86 $1.4B -
What do Analysts Say About UFPT or MASI?
UFP Technologies, Inc. has a consensus price target of $329.50, signalling upside risk potential of 51.75%. On the other hand Masimo Corp. has an analysts' consensus of $183.75 which suggests that it could grow by 29.69%. Given that UFP Technologies, Inc. has higher upside potential than Masimo Corp., analysts believe UFP Technologies, Inc. is more attractive than Masimo Corp..
Company Buy Ratings Hold Ratings Sell Ratings UFPTUFP Technologies, Inc.1 2 0 MASIMasimo Corp.4 3 0 -
Is UFPT or MASI More Risky?
UFP Technologies, Inc. has a beta of 1.103, which suggesting that the stock is 10.324% more volatile than S&P 500. In comparison Masimo Corp. has a beta of 1.262, suggesting its more volatile than the S&P 500 by 26.208%.
-
Which is a Better Dividend Stock UFPT or MASI?
UFP Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Masimo Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UFP Technologies, Inc. pays -- of its earnings as a dividend. Masimo Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UFPT or MASI?
UFP Technologies, Inc. quarterly revenues are $154.6M, which are smaller than Masimo Corp. quarterly revenues of $371.5M. UFP Technologies, Inc.'s net income of $16.4M is lower than Masimo Corp.'s net income of $53.7M. Notably, UFP Technologies, Inc.'s price-to-earnings ratio is 25.17x while Masimo Corp.'s PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UFP Technologies, Inc. is 2.83x versus 4.48x for Masimo Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UFPTUFP Technologies, Inc.2.83x 25.17x $154.6M $16.4M MASIMasimo Corp.4.48x 116.80x $371.5M $53.7M
-
Which has Higher Returns UFPT or VNRX?
VolitionRX Ltd. has a net margin of 10.6% compared to UFP Technologies, Inc.'s net margin of -862.39%. UFP Technologies, Inc.'s return on equity of 18.42% beat VolitionRX Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital UFPTUFP Technologies, Inc.27.66% $2.11 $569.4M VNRXVolitionRX Ltd.50.73% -$0.05 -$24.7M -
What do Analysts Say About UFPT or VNRX?
UFP Technologies, Inc. has a consensus price target of $329.50, signalling upside risk potential of 51.75%. On the other hand VolitionRX Ltd. has an analysts' consensus of $2.60 which suggests that it could grow by 767.53%. Given that VolitionRX Ltd. has higher upside potential than UFP Technologies, Inc., analysts believe VolitionRX Ltd. is more attractive than UFP Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings UFPTUFP Technologies, Inc.1 2 0 VNRXVolitionRX Ltd.4 2 0 -
Is UFPT or VNRX More Risky?
UFP Technologies, Inc. has a beta of 1.103, which suggesting that the stock is 10.324% more volatile than S&P 500. In comparison VolitionRX Ltd. has a beta of 1.258, suggesting its more volatile than the S&P 500 by 25.804%.
-
Which is a Better Dividend Stock UFPT or VNRX?
UFP Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UFP Technologies, Inc. pays -- of its earnings as a dividend. VolitionRX Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UFPT or VNRX?
UFP Technologies, Inc. quarterly revenues are $154.6M, which are larger than VolitionRX Ltd. quarterly revenues of $627.3K. UFP Technologies, Inc.'s net income of $16.4M is higher than VolitionRX Ltd.'s net income of -$5.4M. Notably, UFP Technologies, Inc.'s price-to-earnings ratio is 25.17x while VolitionRX Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UFP Technologies, Inc. is 2.83x versus 20.54x for VolitionRX Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UFPTUFP Technologies, Inc.2.83x 25.17x $154.6M $16.4M VNRXVolitionRX Ltd.20.54x -- $627.3K -$5.4M
-
Which has Higher Returns UFPT or XTNT?
Xtant Medical Holdings, Inc. has a net margin of 10.6% compared to UFP Technologies, Inc.'s net margin of 3.93%. UFP Technologies, Inc.'s return on equity of 18.42% beat Xtant Medical Holdings, Inc.'s return on equity of 3.78%.
Company Gross Margin Earnings Per Share Invested Capital UFPTUFP Technologies, Inc.27.66% $2.11 $569.4M XTNTXtant Medical Holdings, Inc.66.13% $0.01 $82.9M -
What do Analysts Say About UFPT or XTNT?
UFP Technologies, Inc. has a consensus price target of $329.50, signalling upside risk potential of 51.75%. On the other hand Xtant Medical Holdings, Inc. has an analysts' consensus of $1.50 which suggests that it could grow by 143.51%. Given that Xtant Medical Holdings, Inc. has higher upside potential than UFP Technologies, Inc., analysts believe Xtant Medical Holdings, Inc. is more attractive than UFP Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings UFPTUFP Technologies, Inc.1 2 0 XTNTXtant Medical Holdings, Inc.2 0 0 -
Is UFPT or XTNT More Risky?
UFP Technologies, Inc. has a beta of 1.103, which suggesting that the stock is 10.324% more volatile than S&P 500. In comparison Xtant Medical Holdings, Inc. has a beta of -0.052, suggesting its less volatile than the S&P 500 by 105.153%.
-
Which is a Better Dividend Stock UFPT or XTNT?
UFP Technologies, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UFP Technologies, Inc. pays -- of its earnings as a dividend. Xtant Medical Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios UFPT or XTNT?
UFP Technologies, Inc. quarterly revenues are $154.6M, which are larger than Xtant Medical Holdings, Inc. quarterly revenues of $33.3M. UFP Technologies, Inc.'s net income of $16.4M is higher than Xtant Medical Holdings, Inc.'s net income of $1.3M. Notably, UFP Technologies, Inc.'s price-to-earnings ratio is 25.17x while Xtant Medical Holdings, Inc.'s PE ratio is 60.39x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UFP Technologies, Inc. is 2.83x versus 0.67x for Xtant Medical Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income UFPTUFP Technologies, Inc.2.83x 25.17x $154.6M $16.4M XTNTXtant Medical Holdings, Inc.0.67x 60.39x $33.3M $1.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
